Novartis Ag Sponsored ADR(NVS US)
$151.12-5.153.30%Ext:$157.00+5.883.89%(Market Closed · 00:00:04 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY199812/31/1998 | FY199912/31/1999 | FY200012/31/2000 | FY200112/31/2001 | FY200212/31/2002 | FY200312/31/2003 | FY200412/31/2004 | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 13,393.0 | 11,459.0 | 11,435.0 | 6,877.0 | |||||||||||||||||||||||||||
| Short Term Investments | 569.0 | 1,892.0 | 155.0 | 100.0 | |||||||||||||||||||||||||||
| Cash and Short Term Investments | 13,962.0 | 13,351.0 | 11,590.0 | 6,977.0 | |||||||||||||||||||||||||||
| Net Receivables | 9,376.0 | 8,211.0 | 10,934.0 | 9,602.0 | |||||||||||||||||||||||||||
| Inventory | 5,913.0 | 5,723.0 | 6,269.0 | 6,286.0 | |||||||||||||||||||||||||||
| Other Current Assets | 466.0 | 1,434.0 | 514.0 | 3,742.0 | |||||||||||||||||||||||||||
| Total Current Assets | 30,481.0 | 29,704.0 | 30,460.1 | 26,607.0 | |||||||||||||||||||||||||||
| Property, Plant & Equipment | 10,924.0 | 10,873.0 | 12,352.0 | 12,238.0 | |||||||||||||||||||||||||||
| Long Term Investments | 1,827.0 | 1,128.0 | 2,304.0 | 2,431.0 | |||||||||||||||||||||||||||
| Other Non-Current Assets | 2,184.0 | 4,511.0 | 5,417.0 | 4,981.0 | |||||||||||||||||||||||||||
| Total Non-Current Assets | 69,464.0 | 72,542.0 | 85,109.1 | 91,925.0 | |||||||||||||||||||||||||||
| Total Assets | 99,945.0 | 102,246.0 | 115,569.2 | 118,532.0 | |||||||||||||||||||||||||||
| Account Payables | 4,926.0 | 4,572.0 | 4,456.0 | 4,322.0 | |||||||||||||||||||||||||||
| Short Term Debt | 6,084.0 | 8,089.0 | 5,784.0 | 7,617.0 | |||||||||||||||||||||||||||
| Deferred Revenue | 98.0 | 127.0 | - | - | |||||||||||||||||||||||||||
| Other Current Liabilities | 9,837.0 | 10,384.0 | 12,818.0 | 17,357.0 | |||||||||||||||||||||||||||
| Total Current Liabilities | 26,390.0 | 28,692.0 | 27,278.0 | 31,374.0 | |||||||||||||||||||||||||||
| Long Term Debt | 18,436.0 | 21,366.0 | 29,592.1 | 37,447.0 | |||||||||||||||||||||||||||
| Other Non-Current Liabilities | 4,523.0 | 4,075.0 | 2,476.0 | 4,017.0 | |||||||||||||||||||||||||||
| Total Non-Current Liabilities | 26,805.0 | 29,428.0 | 41,742.1 | 48,231.0 | |||||||||||||||||||||||||||
| Total Liabilities | 53,195.0 | 58,120.0 | 69,020.1 | 79,605.0 | |||||||||||||||||||||||||||
| Common Stock | 825.0 | 793.0 | 766.0 | 736.0 | |||||||||||||||||||||||||||
| Retained Earnings | 49,649.0 | 46,561.0 | 44,720.1 | 37,252.0 | |||||||||||||||||||||||||||
| Total Stockholders Equity | 46,667.0 | 44,046.0 | 46,130.1 | 38,512.0 | |||||||||||||||||||||||||||
| Total Liabilities and Equity | 99,945.0 | 102,246.0 | 115,569.2 | 118,532.0 | |||||||||||||||||||||||||||